BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12175091)

  • 1. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
    Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
    Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly.
    Lewerin C; Ljungman S; Nilsson-Ehle H
    J Intern Med; 2007 Jan; 261(1):65-73. PubMed ID: 17222169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
    Hoek FJ; Kemperman FA; Krediet RT
    Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
    Lee BW; Ihm SH; Choi MG; Yoo HJ
    Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia.
    Aso Y; Yoshida N; Okumura K; Wakabayashi S; Matsutomo R; Takebayashi K; Inukai T
    Clin Chim Acta; 2004 Oct; 348(1-2):139-45. PubMed ID: 15369747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma total homocysteine levels in children with type 1 diabetes: relationship with vitamin status, methylene tetrahydrofolate reductase genotype, disease parameters and coronary risk factors.
    Dinleyici EC; Kirel B; Alatas O; Muslumanoglu H; Kilic Z; Dogruel N
    J Trop Pediatr; 2006 Aug; 52(4):260-6. PubMed ID: 16401615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes.
    Harmoinen AP; Kouri TT; Wirta OR; Lehtimäki TJ; Rantalaiho V; Turjanmaa VM; Pasternack AI
    Clin Nephrol; 1999 Dec; 52(6):363-70. PubMed ID: 10604644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
    Ozdemir G; Ozden M; Maral H; Kuskay S; Cetinalp P; Tarkun I
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of total homocysteine plasma concentration in type 2 diabetes.
    Russo GT; Di Benedetto A; Giorda C; Alessi E; Crisafulli G; Ientile R; Di Cesare E; Jacques PF; Raimondo G; Cucinotta D
    Eur J Clin Invest; 2004 Mar; 34(3):197-204. PubMed ID: 15025678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced urinary excretion of homocysteine could be the reason of elevated plasma homocysteine in patients with psychiatric illnesses.
    Ipcioglu OM; Ozcan O; Gultepe M; Ates A; Basoglu C; Cakir E
    Clin Biochem; 2008 Jul; 41(10-11):831-5. PubMed ID: 18457673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?
    Shargorodsky M; Boaz M; Pasternak S; Hanah R; Matas Z; Fux A; Beigel Y; Mashavi M
    Diabetes Metab Res Rev; 2009 Jan; 25(1):70-5. PubMed ID: 19065546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella N; George S
    Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients.
    Villa P; Jiménez M; Soriano MC; Manzanares J; Casasnovas P
    Crit Care; 2005 Apr; 9(2):R139-43. PubMed ID: 15774046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella NA; Zaki MY; El Gebely SA; Mohamedi HM; Aldhahi WA
    Diabet Med; 2006 Aug; 23(8):839-44. PubMed ID: 16911620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
    de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
    J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.